Research
-
First-ever study uses EMRs to spot new disease associations
Vanderbilt University Medical Center researchers and co-authors from four other U.S. institutions from the Electronic Medical Records and Genomics (eMERGE) Network are repurposing genetic data and electronic medical records to perform the first large-scale phenome-wide association study (PheWAS), released today in Nature Biotechnology. Read MoreDec 5, 2013
-
Study gives new meaning to ‘let your fingers do the walking’
A new study has found that skilled typists can’t identify the positions of many of the keys on the QWERTY keyboard and that novice typists don’t appear to learn key locations in the first place. Read MoreDec 4, 2013
-
How to avoid another financial meltdown like 2008-2009
Tighter regulation of financial institutions - especially "shadow" banking institutions - is needed to avoid another economic disaster like that of 2008-2009, says economist Margaret Blair of Vanderbilt Law School. Read MoreDec 3, 2013
-
VU researchers report G protein advancement that could lead to more effective drugs
Thanks in part to a computer program named “Rosetta,” Vanderbilt University researchers are closer to understanding how the ubiquitous G protein is activated – a discovery that could lead to the design of more specific and effective drugs. Read MoreDec 2, 2013
-
Autism narrows brain’s reward response
MRI brain scans reveal that children with autism spectrum disorders respond to a narrower range of familiar rewards. Read MoreNov 27, 2013
-
Mitochondrial mutations not random
A study of mitochondrial DNA mutations suggests they result from a process that selects for particular mutations in certain tissues. Read MoreNov 25, 2013
-
Vanderbilt celebrates 18 elected fellows of the AAAS
Eighteen academic and administrative leaders at Vanderbilt University have been elected fellows of the American Association for the Advancement of Science (AAAS) this year. Read MoreNov 25, 2013
-
Therapeutic target for synovial sarcoma
Inhibitors of a signaling pathway that is critical to synovial sarcoma tumorigenesis may be useful treatments for this aggressive cancer. Read MoreNov 21, 2013
-
Study finds limited resources for injured surgeons
Nearly half of orthopaedic surgeons sustain at least one injury during their career and, in many cases, the resources available to them are inadequate, according to a Vanderbilt study in The Journal of Bone & Joint Surgery. Read MoreNov 21, 2013
-
Research contributions of VUMC nurses highlighted
Nursing research and evidence-based practice at Vanderbilt University Medical Center was on full display Nov. 13 at the annual Nursing Research Day. Read MoreNov 21, 2013
-
Patents should not have to be ‘useful’ to be approved: Vanderbilt professor
New inventions should not have to be useful to merit a patent, says Vanderbilt professor Sean B. Seymore. Read MoreNov 19, 2013
-
Heart Institute studying absorbable coronary stent
Vanderbilt Heart and Vascular Institute is participating in a clinical trial to evaluate a medical device for the treatment of coronary artery disease. Read MoreNov 14, 2013
-
Vanderbilt, Leipzig research collaboration sees strong results
During the past two weeks, the fifth international symposium between Leipzig and Vanderbilt universities was held on the Vanderbilt campus, as seven Leipzig faculty members presented a series of chemical biology-related lectures. Read MoreNov 14, 2013
-
Vision research group names VU graduate student to its board
Vanderbilt graduate student Megan Capozzi has been named the Member-In-Training Board of Trustee to the Association for Research in Vision and Ophthalmology (ARVO). Read MoreNov 14, 2013
-
Family’s support enhances cancer research training
John F. Brock III, chairman and CEO of Coca-Cola Enterprises, his wife, Mary, and their three children have established an endowment to support an oncology fellowship at Vanderbilt-Ingram Cancer Center. The Brock Family Fellowship will provide financial assistance long into the future for young physicians, postdoctoral students and medical investigators who are furthering their training in cancer research. Read MoreNov 14, 2013
-
Immunosuppressive drugs unlikely to raise fetal risk: study
Women with chronic autoimmune diseases who take immunosuppressive medications during their first trimester of pregnancy are not putting their babies at significantly increased risk of adverse outcomes, according to a Vanderbilt study released online by the journal Arthritis and Rheumatism. Read MoreNov 14, 2013
-
Neon projects elite aura for amateur athletes
Bright-colored products and brands do more than just draw attention. They allow people to signal a personal identity that aligns them with elite athletes, explains Vanderbilt marketing professor Jennifer Escalas. Read MoreNov 13, 2013
-
Molecular circuits in ovarian cancer
Vanderbilt researchers have used bioinformatics analysis of gene expression data to describe molecular “circuits” that drive ovarian cancer. Read MoreNov 13, 2013
-
Vanderbilt study: Hiring practices preventing change in law school faculties
Law school faculties are not changing with the times, and a Vanderbilt Law School professor says it may be time to look at hiring practices. Read MoreNov 12, 2013
-
Vanderbilt startup competes for $1M prize in Global Food and Health Innovation Challenge
Nashville startup InvisionHeart is a finalist for the Global Food and Health Innovation Challenge and will compete next week for a $1 million prize. InvisionHeart was created by a group at Vanderbilt University, including biomedical engineering professor Franz Baudenbacher and cardiac anesthesiologist Susan Eagle. Read MoreNov 11, 2013